• Source: KD-414

KD-414 is a COVID-19 vaccine candidate developed by Japanese biotechnology company KM Biologics Co. Results of a phase 1/2 clinical trial for this vaccine were released as a preprint in June 2022.




References

Kata Kunci Pencarian:

• Rumpun suku bangsa Austronesia
• Nelson Mandela
• Sejarah Amerika Serikat
• 2368 Beltrovata
• Jerman Nazi
• 2004 OF6
• 2004 FB16
• 2011 CU4
• 2008 UD202
• Mamalia
• KD-414
• COVID-19 vaccination in Japan
• Kuwaiti dinar
• COVID-19 vaccine clinical research
• Ectodysplasin A receptor
• List of minor planets: 1–1000
• List of equipment of the Malaysian Armed Forces
• Adaalat (TV series)
• List of maritime disasters in World War II
• Vasculitis